These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18823797)

  • 1. Bidirectionally adjustable TIPS reduction by parallel stent and stent-graft deployment.
    Sze DY; Hwang GL; Kao JS; Frisoli JK; Kee ST; Razavi MK; Ahmed A
    J Vasc Interv Radiol; 2008 Nov; 19(11):1653-8. PubMed ID: 18823797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular intrahepatic portosystemic shunt flow reduction with adjustable polytetrafluoroethylene-covered balloon-expandable stents.
    Kroma G; Lopera J; Cura M; Suri R; El-Merhi F; Reading J
    J Vasc Interv Radiol; 2009 Jul; 20(7):981-6. PubMed ID: 19497763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stent-grafts for transjugular intrahepatic portosystemic shunt creation: specialized TIPS stent-graft versus generic stent-graft/bare stent combination.
    Saad WE; Darwish WM; Davies MG; Waldman DL
    J Vasc Interv Radiol; 2010 Oct; 21(10):1512-20. PubMed ID: 20801686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIPS: comparison of shunt patency and clinical outcomes between bare stents and expanded polytetrafluoroethylene stent-grafts.
    Jung HS; Kalva SP; Greenfield AJ; Waltman AC; Walker TG; Athanasoulis CA; Wicky ST
    J Vasc Interv Radiol; 2009 Feb; 20(2):180-5. PubMed ID: 19097918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study.
    Maleux G; Heye S; Verslype C; Nevens F
    J Vasc Interv Radiol; 2007 Aug; 18(8):986-92; quiz 993. PubMed ID: 17675616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical and clinical outcome of transjugular intrahepatic portosystemic stent shunt: bare metal stents (BMS) versus viatorr stent-grafts (VSG).
    Sommer CM; Gockner TL; Stampfl U; Bellemann N; Sauer P; Ganten T; Weitz J; Kauczor HU; Radeleff BA
    Eur J Radiol; 2012 Sep; 81(9):2273-80. PubMed ID: 21784593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endovascular shunt reduction in the management of transjugular portosystemic shunt-induced hepatic encephalopathy: preliminary experience with reduction stents and stent-grafts.
    Maleux G; Verslype C; Heye S; Wilms G; Marchal G; Nevens F
    AJR Am J Roentgenol; 2007 Mar; 188(3):659-64. PubMed ID: 17312051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
    Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
    J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postinterventional passive expansion of partially dilated transjugular intrahepatic portosystemic shunt stents.
    Pieper CC; Sprinkart AM; Nadal J; Hippe V; Meyer C; Schild HH; Thomas D
    J Vasc Interv Radiol; 2015 Mar; 26(3):388-94. PubMed ID: 25541420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal flow and arterioportal shunting after transjugular intrahepatic portosystemic shunt creation.
    Itkin M; Trerotola SO; Stavropoulos SW; Patel A; Mondschein JI; Soulen MC; Tuite CM; Shlansky-Goldberg RD; Faust TW; Reddy KR; Solomon JA; Clark TW
    J Vasc Interv Radiol; 2006 Jan; 17(1):55-62. PubMed ID: 16415133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transjugular intrahepatic portosystemic shunt with an autologous endothelial progenitor cell seeded stent: a porcine model.
    Shi HJ; Cao AH; Chen J; Deng G; Teng GJ
    Acad Radiol; 2010 Mar; 17(3):358-67. PubMed ID: 19962914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded PTFE-covered stent-grafts in the treatment of transjugular intrahepatic portosystemic shunt (TIPS) stenoses and occlusions.
    Echenagusia M; Rodriguez-Rosales G; Simo G; Camuñez F; Bañares R; Echenagusia A
    Abdom Imaging; 2005; 30(6):750-4. PubMed ID: 16245017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI of TIPS with covered stent-grafts: In vitro analysis using a flow phantom and initial clinical experience.
    Itkin M; Patel A; Trerotola SO; Litt HI
    AJR Am J Roentgenol; 2009 Jun; 192(6):W317-20. PubMed ID: 19457796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of transjugular intrahepatic portosystemic shunt (TIPS)-associated refractory hepatic encephalopathy by shunt reduction using the parallel technique: outcomes of a retrospective case series.
    Cookson DT; Zaman Z; Gordon-Smith J; Ireland HM; Hayes PC
    Cardiovasc Intervent Radiol; 2011 Feb; 34(1):92-9. PubMed ID: 21057793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stent-graft narrowed with a lasso catheter: an adjustable TIPS reduction technique.
    Monnin-Bares V; Thony F; Sengel C; Bricault I; Leroy V; Ferretti G
    J Vasc Interv Radiol; 2010 Feb; 21(2):275-80. PubMed ID: 20123211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of parallel transjugular intrahepatic portosystemic stent shunts using uncovered stent: the role of host-related factors.
    Helmy A; Redhead DN; Stanley AJ; Hayes PC
    Liver Int; 2006 Jun; 26(5):572-8. PubMed ID: 16762002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft.
    Fanelli F; Salvatori FM; Rabuffi P; Boatta E; Riggio O; Lucatelli P; Passariello R
    AJR Am J Roentgenol; 2009 Dec; 193(6):1696-702. PubMed ID: 19933667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is sonographic surveillance of polytetrafluoroethylene-covered transjugular intrahepatic portosystemic shunts (TIPS) necessary? A single centre experience comparing both types of stents.
    Pan JJ; Chen C; Geller B; Firpi R; Machicao VI; Caridi JG; Nelson DR; Morelli G
    Clin Radiol; 2008 Oct; 63(10):1142-8. PubMed ID: 18774362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients.
    Rössle M; Siegerstetter V; Euringer W; Olschewski M; Kromeier J; Kurz K; Langer M
    Acta Radiol; 2006 Sep; 47(7):660-6. PubMed ID: 16950701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTFE-encapsulated endovascular stent-graft for transjugular intrahepatic portosystemic shunts: experimental evaluation.
    Haskal ZJ; Davis A; McAllister A; Furth EE
    Radiology; 1997 Dec; 205(3):682-8. PubMed ID: 9393521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.